TKI treatment and erectile dysfunction in men with CML
Part of Blood & lymphatic, Cancer, Heart & circulation, Kidney & urinary, Mental health clinical trials.
This study looks at whether tyrosine kinase inhibitors (TKIs), a common treatment for chronic myeloid leukemia (CML), are linked to erectile dysfunction in men. It aims to help patients and doctors understand possible side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and at least 18 years old, but no older than 75.
- You have chronic myeloid leukemia (CML) in the early (chronic) phase.
- You started your first TKI treatment between January 2015 and January 2022.
- You did not have erectile dysfunction before starting TKI therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how gut bacteria affect the way chronic myeloid leukemia (CML) patients respond to tyrosine kinase inhibitor (TKI) medications. It may help doctors understand why some people have better outcomes than others.
This study tracks the experiences and health outcomes of people with chronic myeloid leukemia (CML) who are taking approved first or second line tyrosine kinase inhibitor (TKI) medicines. It helps doctors learn how these treatments work in everyday care.
This trial looks at how a targeted therapy called TKI (tyrosine kinase inhibitor) affects thyroid function in patients newly diagnosed with chronic myeloid leukemia (CML). It aims to understand any changes in the thyroid gland during treatment.
This trial studies a new drug (KRT-232) combined with a standard CML “TKI” medicine to treat chronic myeloid leukemia (CML) that is resistant or not tolerated after at least one prior TKI. It may help people whose leukemia hasn’t controlled as expected on current treatments.
This study tests whether tadalafil, a daily pill for erectile dysfunction, improves blood vessel health and erectile function. It may help men with erectile dysfunction caused by blood vessel problems.
This study looks at how certain CML treatments called tyrosine kinase inhibitors affect blood sugar and cholesterol levels in people with chronic myeloid leukemia. It may help understand if these drugs change metabolism.
Hear when a new Tyrosine Kinase Inhibitor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.